USMI announced the planned debut in collaboration with the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS). They called the announcement “a ground-breaking achievement in surgical and robotic technology.” They plan to unveil the system at the First Global Surgical Oncology Summit in Jerusalem, Israel. It takes place between Jan. 30, 2024, and Feb. 2, 2024.
Canady delivers cold atmospheric plasma (CAP), a three-dimensional, non-contact biometric pulsed electromagnetic field. CAP selectively targets and kills microscopic tumor cells during surgery without damaging non-cancerous surrounding tissue.
The system features a motorized positioning arm, a speech recognition electrosurgical generator called ORLI and a controller for CAP devices. Its robotic-assisted end effectors offer usability in open, laparoscopic, thoracoscopic, endoscopic and mini-invasive surgical procedures. The system also offers surgeons 10 degrees of freedom, speech activation, AI-powered software and more.
USMI in June won FDA approval for its Canady Flex RoboWrist in open and laparoscopic procedures.
“This technology will transform the landscape of the OR,” USMI CEO Dr. Jerome Canady said. “ORLI is a user-friendly system controlling the entire integrated Smart operating room. The platform will serve as a Siri, Alexa, and Google Home for the operating room.
“This achievement signifies a significant leap forward integrating artificial intelligence and robotics in surgery.”
